EARNINGS AND TRADING: Scancell gets FDA clearance for phase 3 trial
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 1.90p on 28-01-2026 at 15:11:15 |
|---|---|
| Change | -0.055p -2.81% |
| Buy | 2.00p |
| Sell | 1.82p |
| Last Trade: | Buy 2,000.00 at 2.00p |
| Day's Volume: | 957,330 |
| Last Close: | 1.955p |
| Open: | 1.90p |
| ISIN: | GB0003104196 |
| Day's Range | 1.90p - 1.90p |
| 52wk Range: | 1.31p - 5.40p |
| Market Capitalisation: | £5.61m |
| VWAP: | 1.888436p |
| Shares in Issue: | 295.18m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Proteome (PRM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 2,000 | 2.00p | SI Trade |
13:59:23 - 28-Jan-26 |
| Buy* | 152 | 2.00p | SI Trade |
13:59:23 - 28-Jan-26 |
| Sell* | 50,000 | 1.8328p | Ordinary |
13:32:51 - 28-Jan-26 |
| Unknown* | 262,204 | 1.905p | Ordinary |
13:17:14 - 28-Jan-26 |
| Buy* | 5,000 | 2.00p | SI Trade |
12:19:13 - 28-Jan-26 |
| Sell* | 1,700 | 1.81p | SI Trade |
12:19:13 - 28-Jan-26 |
| Buy* | 2,222 | 2.00p | SI Trade |
12:19:13 - 28-Jan-26 |
| Buy* | 450 | 2.00p | SI Trade |
12:19:13 - 28-Jan-26 |
| Unknown* | 4,987 | 1.905p | Ordinary |
12:18:28 - 28-Jan-26 |
| Sell* | 13,786 | 1.8328p | Ordinary |
09:29:14 - 28-Jan-26 |
Proteome (PRM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 26th Jan 2026 7:05 am | RNS | Retail Offer to raise up to £60,000 |
| 26th Jan 2026 7:00 am | RNS | £840,000 Fundraise and Retail Offer |
| 6th Jan 2026 7:00 am | RNS | Two Further Substantial Contracts for PRM |
| 8th Dec 2025 7:00 am | RNS | Substantial contract for Proteome Sciences |
| 25th Nov 2025 7:00 am | RNS | Appointment of Nominated Adviser and Broker |
| 25th Sep 2025 7:00 am | RNS | Interim Results |
| 16th May 2025 1:17 pm | RNS | Result of AGM |
| 16th May 2025 12:00 pm | RNS | AGM Statement |
| 10th Apr 2025 7:00 am | RNS | Final Results |
| 4th Apr 2025 1:00 pm | RNS | Notice of Results and Investor Presentation |